Exact Sciences to participate in J.P. Morgan Healthcare Conference

Published

MADISON, Wis., Jan. 2, 2024 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

(PRNewsfoto/Exact Sciences Corporation)

  • J.P. Morgan Healthcare Conference, San FranciscoPresentation followed by Q&A on Monday, January 8, 2024 at 2:15 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact:Nathan HarrillExact Sciences Corp.investorrelations@exactsciences.com608-535-8659

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-jp-morgan-healthcare-conference-302024275.html

SOURCE Exact Sciences Corporation

In This Story

EXAS